Genomics Collaborative

Designing the Future of Health—Together

The Genomics Collaborative is an initiative to accelerate breakthroughs in precision medicine for the ultimate benefit of patients and health care providers.

 

Collaborating clinicians, patients, advocates and researchers are using FDNA’s next-generation phenotyping (NGP) technologies—powered by artificial intelligence—to analyze patient clinical data and next-generation sequencing (NGS) data.

The result will be real-time discovery of disease biomarkers, advancement of clinical and molecular technologies, and understanding of disease genomics to help answer difficult health questions.